Pharmaceutical methods having dopaminergic activity
US4673681A · kind A · utility
1Cited by
0References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 2, 1986 |
| Grant date | Jun 16, 1987 |
| Priority date | — |
| Expiry date | Apr 2, 2006 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition containing .alpha.-dihydroergocryptine, or a salt thereof, is used in combination with pharmaceutically acceptable carrier means or excipient for the treatment of Parkinson's disease, depression or cephalalgias is disclosed. A method for administering the composition to a patient is also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.